Cephalon, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 3.7K
- Market Cap
- -
- Website
- http://www.cephalon.com
The Nuvigil and Provigil Pregnancy Registry
- Conditions
- Interventions
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 191
- Registration Number
- NCT01792583
- Locations
- 🇺🇸
Teva Pregnancy Registry, West Chester, Pennsylvania, United States
A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT01240694
- Locations
- 🇺🇸
Teva Investigational Site 16, Los Angeles, California, United States
🇺🇸Teva Investigational Site 31, Atlanta, Georgia, United States
🇺🇸Teva Investigational Site 29, Dallas, Texas, United States
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT01135459
- Locations
- 🇨🇿
Teva Investigational Site 200, Olomouc, Czechia
🇪🇸Teva Investigational Site 750, Sevilla, Spain
🇵🇹Teva Investigational Site 701, Amadora, Portugal
Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT00983437
- Locations
- 🇺🇸
Teva Investigational Site 8, Houston, Texas, United States
🇺🇸Teva Investigational Site 20, Houston, Texas, United States
🇺🇸Teva Investigational Site 1, Orlando, Florida, United States
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
- First Posted Date
- 2009-05-06
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT00893789
- Locations
- 🇺🇸
Teva Investigational Site 61, Germantown, Tennessee, United States
🇺🇸Teva Investigational Site 26, Atlanta, Georgia, United States
🇺🇸Teva Investigational Site 56, Lincoln, Nebraska, United States
Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Cephalon, Inc.
- Target Recruit Count
- 126
- Registration Number
- NCT00712881
- Locations
- 🇩🇪
Teva Investigational Site 30, Aachen, Germany
🇧🇪Teva Investigational Site 9, Brussels, Belgium
🇦🇹Teva Investigational Site 15, Wien, Austria